Literature DB >> 10233964

The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein.

F Z Yadani1, A Kohl, C Préhaud, A Billecocq, M Bouloy.   

Abstract

The ambisense S segment of Rift Valley fever (RVF) virus (a phlebovirus in the Bunyaviridae family) codes for two proteins: the viral complementary-sense RNA for the N nucleoprotein and the genomic-sense RNA for the nonstructural protein NSs. Except for the fact that the NSs protein is phosphorylated and forms filamentous structures in the nuclei of infected cells (R. Swanepoel and N. K. Blackburn, J. Gen. Virol. 34:557-561, 1977), its role is poorly understood, especially since the replication cycle of all these viruses takes place in the cytoplasm. To investigate the mechanisms involved in filament formation, we expressed NSs in mammalian cells via a recombinant Semliki Forest virus and demonstrated that the protein alone was able to form structures similar to those observed in RVF virus-infected cells, indicating that the presence of other RVF virus proteins is not required for filament formation. The yeast two-hybrid system was used to show that the protein interacts with itself and to map the interacting domains. Various deletion and substitution mutants were constructed, and the mutant proteins were analyzed by immunoprecipitation, Western blotting and immunofluorescence. These experiments indicated that the 10 to 17 amino acids of the carboxy-terminal domain were involved in self-association of the protein and that deletion of this acidic carboxy-terminal domain prevents the protein from forming filaments but does not affect its nuclear localization. The role of two phosphorylation sites present in this domain was also investigated, but they were not found to have a major influence on the formation of the nuclear filament.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233964      PMCID: PMC112546     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 2.  Nuclear import and export of viruses and virus genomes.

Authors:  G R Whittaker; A Helenius
Journal:  Virology       Date:  1998-06-20       Impact factor: 3.616

3.  Identification of the N and NSS proteins coded by the ambisense S RNA of Punta Toro phlebovirus using monospecific antisera raised to baculovirus expressed N and NSS proteins.

Authors:  H A Overton; T Ihara; D H Bishop
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

4.  Morphology and development of Rift Valley fever virus in Vero cell cultures.

Authors:  D S Ellis; P V Shirodaria; E Fleming; D I Simpson
Journal:  J Med Virol       Date:  1988-02       Impact factor: 2.327

5.  Protein synthesis in Rift Valley fever virus-infected cells.

Authors:  J K Struthers; R Swanepoel; S P Shepherd
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

6.  Morphogenesis of sandfly viruses (Bunyaviridae family).

Authors:  J F Smith; D Y Pifat
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

7.  Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development.

Authors:  H Caplen; C J Peters; D H Bishop
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

8.  Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells.

Authors:  R Swanepoel; N K Blackburn
Journal:  J Gen Virol       Date:  1977-03       Impact factor: 3.891

9.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

10.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

View more
  43 in total

1.  The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.

Authors:  P Vialat; A Billecocq; A Kohl; M Bouloy
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Authors:  José-Carlos Fernandez; Agnès Billecocq; Jean Paul Durand; Catherine Cêtre-Sossah; Eric Cardinale; Philippe Marianneau; Michel Pépin; Noël Tordo; Michèle Bouloy
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

3.  Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.

Authors:  Kumari G Lokugamage; Krishna Narayanan; Keisuke Nakagawa; Kaori Terasaki; Sydney I Ramirez; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

Review 4.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

Review 5.  Molecular aspects of Rift Valley fever virus and the emergence of reassortants.

Authors:  Natasha N Gaudreault; Sabarish V Indran; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Virus Genes       Date:  2018-11-13       Impact factor: 2.332

6.  Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.

Authors:  M Bouloy; C Janzen; P Vialat; H Khun; J Pavlovic; M Huerre; O Haller
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.

Authors:  Birte Kalveram; Olga Lihoradova; Sabarish V Indran; Nandadeva Lokugamage; Jennifer A Head; Tetsuro Ikegami
Journal:  Virology       Date:  2012-10-12       Impact factor: 3.616

9.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

10.  Development of a RVFV ELISA that can distinguish infected from vaccinated animals.

Authors:  Anita K McElroy; César G Albariño; Stuart T Nichol
Journal:  Virol J       Date:  2009-08-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.